Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 4 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Results 1 - 20 of 50 : 1 2 3 Next »

Recs

0
Member Avatar benyboy (< 20) Submitted: 7/14/2015 6:48:14 PM : Outperform Start Price: $237.20 VRX Score: +7.16

its good...

Recs

0
Member Avatar NechesInvst (99.67) Submitted: 6/19/2015 11:17:33 AM : Outperform Start Price: $230.93 VRX Score: +10.40

Just checking to see if Bill Ackman can pick growth companies.

Recs

0
Member Avatar stocky5 (42.06) Submitted: 6/18/2015 10:00:17 AM : Outperform Start Price: $232.34 VRX Score: +10.00

Forward PEG is 0.67 (CHEAP), with a forward growth rate of over 27%. The stock is near oversold levels, creating a good entry point. Extremely well run company with strong shareholder friendly activist oversight.

Recs

0
Member Avatar luremaster (44.83) Submitted: 5/8/2015 3:57:19 AM : Outperform Start Price: $221.42 VRX Score: +14.87

great management

Recs

0
Member Avatar AnsgarJohn (98.30) Submitted: 5/5/2015 9:00:44 AM : Underperform Start Price: $219.85 VRX Score: -15.06

http://fortune.com/2015/05/04/bill-ackman-valeant-could-be-next-berkshire-hathaway/

Recs

0
Member Avatar moneyman999 (42.67) Submitted: 2/15/2015 1:44:00 AM : Underperform Start Price: $168.17 VRX Score: -50.53

Simply overvalued,volitilty will be high but gains will be low.

Recs

0
Member Avatar freecapital (75.35) Submitted: 2/10/2015 11:37:21 PM : Outperform Start Price: $162.74 VRX Score: +54.21

Donville

Recs

0
Member Avatar 10x2 (54.84) Submitted: 1/30/2015 8:17:37 PM : Outperform Start Price: $158.00 VRX Score: +56.38

Sabrient pick.

Recs

0
Member Avatar reddingrunner (95.40) Submitted: 1/16/2015 1:33:28 PM : Outperform Start Price: $155.58 VRX Score: +58.27

sabrient bakers dozen 2015

Recs

0
Member Avatar 1russianguy (93.13) Submitted: 1/15/2015 9:17:14 AM : Outperform Start Price: $158.00 VRX Score: +56.38

Sabrient

Recs

0
Member Avatar mrudolph72 (61.87) Submitted: 1/14/2015 3:10:34 PM : Outperform Start Price: $157.00 VRX Score: +56.75

Sabrient

Recs

0
Member Avatar Defshark82 (77.83) Submitted: 12/31/2014 11:46:13 AM : Outperform Start Price: $143.88 VRX Score: +75.33

top pick JPM tracker

Recs

0
Member Avatar mlarms (21.14) Submitted: 7/31/2014 2:24:29 AM : Outperform Start Price: $118.88 VRX Score: +106.12

My big Pharma pick

Recs

0
Member Avatar chipotlepickle (98.02) Submitted: 6/15/2014 5:21:26 PM : Underperform Start Price: $118.81 VRX Score: -105.29

Running out of one time events.

Recs

0
Member Avatar ValueSwap (< 20) Submitted: 6/12/2014 3:29:27 PM : Outperform Start Price: $120.02 VRX Score: +102.84

How R&D should work and their aggressive capitalizing interest to generate a low tax rate create much fuzz about the company, which in turn give a long term holder a good entry point

Recs

0
Member Avatar IanERichards (83.60) Submitted: 6/4/2014 7:37:57 AM : Outperform Start Price: $131.15 VRX Score: +84.35

Focus on capital allocation - creative approach to making a deal

Recs

0
Member Avatar RickP (84.92) Submitted: 5/18/2014 6:17:33 PM : Outperform Start Price: $125.85 VRX Score: +89.73

Great CEO......

Fantastic future regardless of whether Allergen merger occurs or not

Recs

0
Member Avatar RLBOWERSOX (93.05) Submitted: 3/31/2014 4:40:45 PM : Outperform Start Price: $132.07 VRX Score: +80.17

One of the final four

Recs

0
Member Avatar mrwrong (< 20) Submitted: 3/29/2014 2:06:48 PM : Underperform Start Price: $129.27 VRX Score: -83.76

growth will stall as company comes a cropper, with a bridge too far. most all- do, but i like it now.

Recs

0
Member Avatar motto1628 (67.24) Submitted: 3/25/2014 4:05:57 PM : Outperform Start Price: $132.26 VRX Score: +79.54

- genius CEO in acquisition
- diversified pharmaceutical products
- stock advisor pick

Results 1 - 20 of 50 : 1 2 3 Next »

Featured Broker Partners


Advertisement